Major Vaccine Breakthrough Could Spell Hope For Treating Aggressive Breast Cancer
The results of a small clinical trial of a vaccine for an aggressive form of breast cancer have been presented at a conference, and the researchers say there’s cause for optimism. The 16 patients in the trial all received three doses of the vaccine, with the majority developing a robust immune response and no major side-effects reported.
